Skip to main content
Heart logoLink to Heart
. 1997 Jun;77(6):489–490. doi: 10.1136/hrt.77.6.489

Should the contribution of ACE gene polymorphism to left ventricular hypertrophy be reconsidered?

H Montgomery
PMCID: PMC484783  PMID: 9227284

Full text

PDF
489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloem L. J., Manatunga A. K., Pratt J. H. Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension. 1996 Jan;27(1):62–66. doi: 10.1161/01.hyp.27.1.62. [DOI] [PubMed] [Google Scholar]
  2. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., Luc G., Bard J. M., Bara L., Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 Oct 15;359(6396):641–644. doi: 10.1038/359641a0. [DOI] [PubMed] [Google Scholar]
  3. Castellano M., Muiesan M. L., Rizzoni D., Beschi M., Pasini G., Cinelli A., Salvetti M., Porteri E., Bettoni G., Kreutz R. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in a general population. The Vobarno Study. Circulation. 1995 Jun 1;91(11):2721–2724. doi: 10.1161/01.cir.91.11.2721. [DOI] [PubMed] [Google Scholar]
  4. Danser A. H., Schalekamp M. A., Bax W. A., van den Brink A. M., Saxena P. R., Riegger G. A., Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation. 1995 Sep 15;92(6):1387–1388. doi: 10.1161/01.cir.92.6.1387. [DOI] [PubMed] [Google Scholar]
  5. Gharavi A. G., Lipkowitz M. S., Diamond J. A., Jhang J. S., Phillips R. A. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol. 1996 Jun 15;77(15):1315–1319. doi: 10.1016/s0002-9149(96)00198-1. [DOI] [PubMed] [Google Scholar]
  6. Hamon M., Amant C., Bauters C., Richard F., Helbecque N., McFadden E., Lablanche J. M., Bertrand M., Amouyel P. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. Heart. 1997 Jun;77(6):502–505. doi: 10.1136/hrt.77.6.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Iwai N., Ohmichi N., Nakamura Y., Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation. 1994 Dec;90(6):2622–2628. doi: 10.1161/01.cir.90.6.2622. [DOI] [PubMed] [Google Scholar]
  8. Lechin M., Quiñones M. A., Omran A., Hill R., Yu Q. T., Rakowski H., Wigle D., Liew C. C., Sole M., Roberts R. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation. 1995 Oct 1;92(7):1808–1812. doi: 10.1161/01.cir.92.7.1808. [DOI] [PubMed] [Google Scholar]
  9. Levy D., Garrison R. J., Savage D. D., Kannel W. B., Castelli W. P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990 May 31;322(22):1561–1566. doi: 10.1056/NEJM199005313222203. [DOI] [PubMed] [Google Scholar]
  10. Lindpaintner K., Lee M., Larson M. G., Rao V. S., Pfeffer M. A., Ordovas J. M., Schaefer E. J., Wilson A. F., Wilson P. W., Vasan R. S. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med. 1996 Apr 18;334(16):1023–1028. doi: 10.1056/NEJM199604183341604. [DOI] [PubMed] [Google Scholar]
  11. Lièvre M., Guéret P., Gayet C., Roudaut R., Haugh M. C., Delair S., Boissel J. P. Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. HYCAR Study Group. Hypertension. 1995 Jan;25(1):92–97. doi: 10.1161/01.hyp.25.1.92. [DOI] [PubMed] [Google Scholar]
  12. Marian A. J., Yu Q. T., Workman R., Greve G., Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 1993 Oct 30;342(8879):1085–1086. doi: 10.1016/0140-6736(93)92064-z. [DOI] [PubMed] [Google Scholar]
  13. Prasad N., O'Kane K. P., Johnstone H. A., Wheeldon N. M., McMahon A. D., Webb D. J., MacDonald T. M. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele. QJM. 1994 Nov;87(11):659–662. [PubMed] [Google Scholar]
  14. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 Oct;86(4):1343–1346. doi: 10.1172/JCI114844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schunkert H., Dzau V. J., Tang S. S., Hirsch A. T., Apstein C. S., Lorell B. H. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest. 1990 Dec;86(6):1913–1920. doi: 10.1172/JCI114924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schunkert H., Hense H. W., Holmer S. R., Stender M., Perz S., Keil U., Lorell B. H., Riegger G. A. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994 Jun 9;330(23):1634–1638. doi: 10.1056/NEJM199406093302302. [DOI] [PubMed] [Google Scholar]
  17. Shanmugam V., Sell K. W., Saha B. K. Mistyping ACE heterozygotes. PCR Methods Appl. 1993 Oct;3(2):120–121. doi: 10.1101/gr.3.2.120. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES